Over expression of BCL2 slows down cell growth and very high expression can promote cell death, while lower BCL2 expression can be a sign of inhibition of apoptosis in human breast and endometrial carcinoma tissues [13], [14]. The gene discussed is BCL2; the disease is endometrial carcinoma.